In conclusion, lower IGF-I levels (≤135 ng/mL) are significantly related to risk of stroke, independent from other traditional and emerging risk factors, suggesting that they may play a role in the pathogenesis of AIS. This evidence concerns the gene IGF1 and stroke disorder.